Distribution of retinal layer atrophy in patients with parkinson disease and association with disease severity and duration

American Journal of Ophthalmology

Volumn 157, Issue 2, 2014, Pages

  Garcia Martin, Elena ^a,b   Larrosa, Jose M ^a,b   Polo, Vicente ^a,b   Satue, Maria ^a,b   Marques, Marcia L ^a,b,c   Alarcia, Raquel ^a   Seral, Maria ^a   Fuertes, Isabel ^a,b   Otin, Sofia ^a,b   Pablo, Luis E ^a,b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c Instituto de Genética Ocular   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXONAL INJURY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON DISEASE; PRIORITY JOURNAL; RETINA BIPOLAR GANGLION CELL; RETINA DISEASE; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINA NEUROEPITHELIAL LAYER; RETINA OUTER MOLECULAR LAYER; RETINAL LAYER ATROPHY; RETINAL NERVE FIBER LAYER THICKNESS;

ADULT; AGED; AGED, 80 AND OVER; ATROPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES; RETINAL NEURONS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84892621779     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.09.028     Document Type: Article

References (34)

1. D.H. Know, J.M. Kim, and S.H. Oh et al. Seven-Tesla Magnetic resonance images of the substantia nigra in Parkinson disease Ann Neurol 71 2 2012 267 277
2. R.E. Gross, R.L. Watts, and R.A. Hauser et al. Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial Lancet Neurol 10 6 2011 509 519
3. N.K. Archibald, M.P. Clarke, U.P. Mosimann, and D.J. Burn The retina in Parkinson's disease Brain 132 Pt 5 2009 1128 1145
4. U. Schraermeyer, J. Kopitz, and S. Peters et al. Tyrosinase biosynthesis in adult mammalian retinal pigment epithelial cells Exp Eye Res 83 2 2006 315 321
5. M.E. Hajee, W.F. March, and D.R. Lazzaro et al. Inner retinal layer thinning in Parkinson disease Arch Ophthalmol 127 6 2009 737 741
6. O. Altintaş, P. Işeri, B. Ozkan, and Y. Caǧlar Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease Doc Ophthalmol 116 2 2008 137 146
7. E. Garcia-Martin, L.E. Pablo, and R. Herrero et al. Diagnostic ability of a linear discriminant function for Spectral domain optical coherence tomography in multiple sclerosis patients Ophthalmology 119 8 2012 1705 1711
8. E. Garcia-Martin, M. Satue, and I. Fuertes et al. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson Ophthalmology 119 10 2012 2161 2167
9. M.A. Seigo, E.S. Sotirchos, and S. Newsome et al. In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques J Neurol 259 10 2012 2119 2130
10. E. Garcia-Martin, V. Pueyo, and C. Almarcegui et al. Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients Br J Ophthalmol 95 11 2011 1577 1582
11. E. Garcia-Martin, V. Pueyo, and J.R. Ara et al. Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients Mult Scler 17 7 2011 830 837
12. M. Hoehn, and M. Yahr Parkinsonism: onset, progression and mortality Neurology 17 5 1967 427 442
13. C.G. Goetz, W. Poewe, and O. Rascol et al. Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. The movement disorder society task force on rating scales for Parkinson's disease Mov Disord 19 9 2004 1020 1028
14. Movement disorder society task force on rating scales for Parkinson's disease The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations Mov Disord 18 7 2003 738 750
15. J. Jankovic Parkinson's disease: clinical features and diagnosis J Neurol Neurosurg Psychiatry 79 4 2008 368 376
16. P. Albrecht, A.K. Müller, and M. Südmeyer et al. Optical coherence tomography in parkinsonian syndromes PLoS One 7 4 2012 e34891
17. E. Garcia-Martin, V. Pueyo, and I. Pinilla et al. Fourier-domain OCT in multiple sclerosis patients: reproducibility and ability to detect retinal nerve fiber layer atrophy Invest Ophthalmol Vis Sci 52 7 2011 4124 4131
18. J.S. Schuman, T. Pedut-Kloizman, and E. Hertzmark et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography Ophthalmology 103 11 1996 1889 1898
19. Z. Wu, J. Huang, L. Dustin, and S.R. Sadda Signal strength is an important determinant of accuracy of nerve fiber layer thickness measurement by optical coherence tomography J Glaucoma 18 3 2009 213 216
20. A. Maresca, C. la Morgia, and L. Caporali et al. The optic nerve: a "mito-window" on mitochondrial neurodegeneration Mol Cell Neurosci 55 2013 62 76
21. C. La Morgia, P. Barboni, and G. Rizzo et al. Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol 20 1 2013 198 201
22. G.D. Aaker, J.S. Myung, and J.R. Ehrlich et al. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography Clin Ophthalmol 4 2010 1427 1432
23. P. Albrecht, M. Ringelstein, and A.K. Müller et al. Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography Mult Scler 18 10 2012 1422 1429
24. P. Jindahra, A. Petrie, and G.T. Plant Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography Brain 132 Pt 3 2009 628 634
25. J.S. Mehta, and G.T. Plant Optical coherence tomography (OCT) findings in congenital/long-standing homonymous hemianopia Am J Ophthalmol 140 4 2005 727 729
26. D.S. Reich, S.A. Smith, and E.M. Gordon-Lipkin et al. Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability Arch Neurol 66 8 2009 998 1006
27. S. Kriks, J.W. Shim, and J. Piao et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease Nature 480 7378 2011 547 551
28. C.R. Freed, W. Zhou, and R.E. Breeze Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials Neurotherapeutics 8 4 2011 549 561
29. Z. Lei, Y. Jiang, and T. Li et al. Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease J Neuropathol Exp Neurol 70 9 2011 736 747
30. F. Stocchi, O. Rascol, and K. Kieburtz et al. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study Ann Neurol 68 1 2010 18 27
31. D.J. Brooks Imaging approaches to Parkinson disease J Nucl Med 51 4 2010 596 609
32. D.J. Gelb, E. Oliver, and S. Gilman Diagnostic criteria for Parkinson disease Arch Neurol 56 1 1999 33 39
33. C. Almarcegui, I. Dolz, and V. Pueyo et al. Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients Neurophysiol Clin 40 3 2010 129 135
34. E.C. Davies, K.M. Galetta, and D.J. Sackel et al. Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique J Neuroophthalmol 31 3 2011 260 264